Clearline Capital »

Mirati Therapeutics shares owned by Clearline Capital

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Clearline Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 51k 58.75
2023-09-30 $2.2M 51k 43.56
2023-06-30 $2.0M 56k 36.13